In summary, this study demonstrates that administration of hUC-MSCs alleviates steatosis, inflammation and fibrosis in NAFLD via inducing autophagy, which is mediated through the AMPK-mTOR-TFEB signaling pathway. Here, TFEB is linked to steatosis.